semaglutide dapagliflozin Frontiers Type 2 diabetes mellitus pharmacological

Phase 2 data showed the 8mg combined group achieved 22.8% mean weight reduction at 48 weeks, which is only 1.4 percentage points less than the 12mg group

GLP-1 receptor agonists reduce intracranial pressure

Centrally, they manage appetite and cravings by modulating the reward circuitry in the brain, while peripherally, they correct systemic metabolism and reduce hepatic fat accumulation ( Importantly, this mechanistic framework is increasingly supported by large-scale clinical outcome data

All analyses were performed using GraphPad Prism software version 6.01 for Windows (San Diego, California, USA)

It's the gold standard access path